Show simple item record

dc.contributor.authorVerhagen, Nathaniel B
dc.contributor.authorKoerber, Nicolas K
dc.contributor.authorSzabo, Aniko
dc.contributor.authorTaylor, Bradley
dc.contributor.authorWainaina, J Njeri
dc.contributor.authorEvans, Douglas B
dc.contributor.authorKothari, Anai N
dc.date.accessioned2023-05-12T15:18:04Z
dc.date.available2023-05-12T15:18:04Z
dc.date.issued2022-12-07
dc.identifier.citationVerhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN; N3C Consortium. Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. Ann Surg Oncol. 2023 Mar;30(3):1305-1308. doi: 10.1245/s10434-022-12916-z. Epub 2022 Dec 7. PMID: 36479662; PMCID: PMC9734328.en_US
dc.identifier.eissn1534-4681
dc.identifier.doi10.1245/s10434-022-12916-zen_US
dc.identifier.pmid36479662
dc.identifier.urihttp://hdl.handle.net/20.500.14038/52073
dc.descriptionThe UMass Center for Clinical and Translational Science (UMCCTS), UL1TR001453, provided data for this study.en_US
dc.description.abstractEarly in the COVID-19 pandemic, mortality rates were observed to exceed 25% in patients who developed postoperative SARS-CoV-2 infections.1 This prompted numerous perioperative structural and process changes to mitigate this risk.2,3 As the pandemic has progressed, the emergence of novel therapeutic and preventative measures have proven effective in decreasing the overall burden of SARS-CoV-2 infection. These advances likely reduce the risk in surgical patients; however, this has not been reexamined at a population level. This study reports 30-day adverse postoperative event rates in patients who develop postoperative COVID-19 and measures the impact of vaccination on these outcomes.en_US
dc.language.isoenen_US
dc.relation.ispartofAnnals of Surgical Oncologyen_US
dc.relation.urlhttps://doi.org/10.1245/s10434-022-12916-zen_US
dc.rightsThis is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022en_US
dc.subjectUMCCTS fundingen_US
dc.titleVaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgeryen_US
dc.typeJournal Articleen_US
dc.source.journaltitleAnnals of surgical oncology
dc.source.volume30
dc.source.issue3
dc.source.beginpage1305
dc.source.endpage1308
dc.source.countryUnited States
dc.source.countryUnited States
dc.identifier.journalAnnals of surgical oncology
refterms.dateFOA2023-05-12T15:18:05Z
dc.contributor.departmentCenter for Clinical and Translational Scienceen_US


Files in this item

Thumbnail
Name:
s10434-022-12916-z.pdf
Size:
246.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record